The Lancet Summit2nd biennial conference on cancer control in China
Available Fields
The Lancet Summit: 2nd Biennial Conference on Cancer Control in China 2027 is an international oncology conference bringing together clinicians, researchers, public-health specialists, policymakers, and other cancer professionals. The programme focuses on haematological cancers, women’s cancers, cancer imaging, AI, digital medicine, public health, and cancer-control policy. It will take place in Shanghai, China, in March 2027, and abstract submissions are currently open.
Opportunity
The Lancet Summit: 2nd Biennial Conference on Cancer Control in China
Type
International Scientific Conference / Call for Abstracts
Organizer
The Lancet Group / Elsevier
The programme involves several Lancet journals, including The Lancet Haematology, The Lancet Obstetrics, Gynaecology & Women’s Health, The Lancet Medical Imaging & Theranostics, and The Lancet.
Country
China
Location
Shanghai, China
Conference Dates
The official event header lists:
18–21 March 2027
The main scientific conference programme is described as running over three days from 19–21 March 2027.
Event Format
In-person conference
The official programme describes the event as taking place physically in Shanghai and does not currently state a virtual or hybrid attendance option.
Main Conference Tracks
The scientific programme includes three parallel tracks:
- Haematological Cancers
- Women’s Cancers
- Cancer Imaging
There will also be plenary sessions and a dedicated half-day symposium on AI in cancer research.
Abstract Topics
Abstracts are invited in areas including:
- Clinical trials
- Original research
- Translational research
- Global oncology
- Public health
- Health policy
- AI and digital medicine
- Haematological cancers
- Breast cancer
- Gynaecological cancers
- Cancer imaging
- Nuclear medicine
- Theranostics
Eligible Research Types
The conference accepts original research including:
- Clinical trials
- Prospective studies
- Retrospective analyses
- Meta-analyses
- Observational cohort studies
- Case-control studies
It does not accept reviews, opinion articles, case series, or case reports. Research should have appropriate ethics approval, and clinical trials should be prospectively registered.
Presentation Types
Selected abstracts may be presented as:
- Oral presentations
- Poster presentations
The strongest submissions may be selected for oral presentation, while other accepted abstracts will be presented as posters.
Publication
All accepted abstracts will be published in The Lancet Regional Health – Western Pacific.
Who Can Participate
The conference is relevant to:
- Physicians
- Oncologists
- Surgeons
- Nurses
- Pathologists
- Radiologists
- Palliative care specialists
- Epidemiologists
- Public-health professionals
- Researchers
- Policymakers
Abstract Submission Deadline
16 October 2026
Author Notification
11 December 2026
Author Registration Deadline
8 January 2027
Early-Bird Registration Deadline
8 January 2027
Registration Fees
Early-bird rates before 8 January 2027 include:
- Student: USD 400
- Academic: USD 500
- Industry: USD 600
- Chinese national student: USD 350
- Chinese national delegate: USD 450
The student rate is for participants registered for a higher degree, and proof of student/trainee status is required.
Ready to Apply?
Review the details above, then use the links below to apply or visit the official page.
Related Conferences
ISDP 2026 Annual Meeting — Late-Breaking Abstract Submissions
International Society for Developmental Psychobiology (ISDP)
CFP: TLA Magazine Inaugural Issue—Literature, Memory, and Culture
The Literary Archive, ILLCR (Private) Limited